Global Veterinary Oncology Industry (2020 to 2027)


Dublin, June 10, 2021 (GLOBE NEWSWIRE) – The “Veterinary Oncology – Global Market Trajectory and Analysis” report was added to ResearchAndMarkets.com offer.

Amid the COVID-19 crisis, the global veterinary oncology market, estimated at US $ 215.4 million in 2020, is expected to reach a revised size of US $ 400.2 million by 2027, with a CAGR of 9.3% over the analysis period 2020-2027.

Radiology, one of the segments analyzed in the report, is expected to register a CAGR of 8.6% and reach $ 115.9 million by the end of the analysis period. After an initial analysis of the business implications of the pandemic and the induced economic crisis, the growth of the Chemotherapy segment is readjusted to a revised CAGR of 10% for the next 7-year period.

The US market is estimated at $ 58.3 million, while China is expected to grow at 12.4% CAGR

The veterinary oncology market in the United States is estimated at US $ 58.3 million in 2020. China, the world’s second largest economy, is expected to reach a projected market size of US $ 83.1 million by 2027, with a CAGR of 12.2%. during the analysis period 2020 to 2027. Other notable geographies include Japan and Canada, each forecasting growth of 6.3% and 7.9% respectively during the period 2020-2027. In Europe, Germany is expected to grow by around 7.2% CAGR.

Immunotherapy segment to register 9.7% CAGR

In the global immunotherapy segment, the United States, Canada, Japan, China and Europe will lead the estimated 9% CAGR for this segment. These regional markets representing a combined market size of US $ 32.4 million in 2020 will reach a projected size of US $ 59.3 million by the end of the analysis period. China will remain among the fastest growing countries in this group of regional markets. Led by countries such as Australia, India and South Korea, the Asia-Pacific market is expected to reach $ 57.1 million by 2027, while Latin America will grow at a CAGR of 11 , 1% during the analysis period.

Some competitors (40 in total):

  • Accuray Incorporated

  • Boehringer Ingelheim International GmbH

  • Elanco

  • Karyopharm Therapeutics, Inc.

  • Morphogenesis, Inc.

  • Nippon Zenyaku Kogyo Co., Ltd.

  • Health

  • PetCure Oncology

  • Regeneus Ltd.

  • Varian Medical System, Inc.

Main topics covered:

I. METHODOLOGY

II. ABSTRACT

1. MARKET OVERVIEW

  • Overview of the influencer market

  • Global market trajectories

  • Impact of Covid-19 and an impending global recession

2. FOCUS ON CERTAIN PLAYERS

3. MARKET TRENDS AND FACTORS

4. WORLD MARKET PERSPECTIVE

III. MARKET ANALYSIS

  • UNITED STATES

  • CANADA

  • JAPAN

  • CHINA

  • EUROPE

  • FRANCE

  • GERMANY

  • ITALY

  • UK

  • SPAIN

  • RUSSIA

  • THE REST OF EUROPE

  • ASIA PACIFIC

  • AUSTRALIA

  • INDIA

  • SOUTH KOREA

  • REST OF ASIA PACIFIC

  • LATIN AMERICA

  • ARGENTINA

  • BRAZIL

  • MEXICO

  • REST OF LATIN AMERICA

  • MIDDLE EAST

  • IRAN

  • ISRAEL

  • SAUDI ARABIA

  • UNITED ARAB EMIRATES

  • REST OF MIDDLE EAST

  • AFRICA

IV. COMPETITION

For more information on this report, visit https://www.researchandmarkets.com/r/qzs0db

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

About Hector Hedgepeth

Check Also

Digital Veterinary Scales Market Trends, Growth, Demand, Opportunities, Scope and Forecast by 2030 – Instant Interview

The report presents the current scenario of the Digital Veterinary Scales Market, Market by Region, …

Leave a Reply

Your email address will not be published.